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Intentional coverage of the celiac artery (CA) can extend the distal landing zone necessary for thoracic endovascular aortic
repair. A comprehensive review identiﬁed 93 cases in 17 reports describing this technique. The majority (87%) were
elective procedures. Prior to endograft deployment, 21 patients underwent CA embolization. Of the remaining, three
developed type II endoleaks from the CA requiring treatment. The superior mesenteric artery (SMA) was stented in 18
patients during the operative procedure, with one patient undergoing delayed stent placement. There were ﬁve iliac artery
injuries but no other intraoperative complications. The 30-day mortality rate was 9.7% with three cases attributed to
foregut ischemia. Overall, this procedure is technically safe but is associated with a signiﬁcant risk of death and morbidity.
Furthermore, durability is unclear as long-term data are lacking. Careful patient selection, preoperative determination of
adequate CA-SMA collaterals, and demonstration of postprocedure SMA patency are all mandatory components of this
procedure. However, the development of foregut ischemia cannot be reliably predicted, and patients should be monitored
closely for this unique postoperative complication. (J Vasc Surg 2013;58:270-5.)Thoracic endovascular aortic repair (TEVAR) was ﬁrst
introduced in 1994.1 It is now considered a viable alterna-
tive to standard open aortic repair due to its lower perio-
perative morbidity and mortality rates.2 For durable
success with TEVAR, there need to be appropriate landing
zones for secure ﬁxation of the endograft. A minimum seal-
ing length of 2 cm of normal aortic tissue is considered
adequate, although longer seal zones are desired to prevent
late complications. The most common anatomic exclusion
for TEVAR is the lack of adequate proximal or distal
landing zones.3
To extend the proximal landing zone, intentional
coverage of the left subclavian artery (with or without
revascularization) can safely be performed and well-toler-
ated.3 Extra-anatomic arterial revascularization (such as
carotid-carotid bypass or total arch debranching) is another
alternative to extend the proximal landing zone.4 Approx-
imately 15% of patients with descending thoracic aortic
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is a potential option, this procedure is associated with
high rates of periprocedural adverse events (including
paraplegia and mortality). While excellent outcomes
have been reported at select high-volume centers of excel-
lence (mortality rate w8%), the overall perioperative
mortality rate of open repair of intact TAAs in the United
States is 22%.6-8 The use of branched or fenestrated endog-
rafts is a potential endovascular option, and the reported
literature shows encouraging results.6,9,10 However, these
procedures can be technically challenging, and the devices
require several weeks to be custom made and remain avail-
able on a limited basis. Alternatively, a hybrid debranching
approach (combining visceral bypasses with TEVAR) was
proposed over a decade ago.11 Reports on the outcomes
of hybrid procedures present disparate results, with some
demonstrating improved outcomes, while some showing
no signiﬁcant improvement compared with standard open
repair.12-14 In addition, there have been limited reports
on the use of “periscope” grafts into the mesenteric
branches to extend the distal landing zone.15,16
A potential alternative to extend the distal landing zone
is the intentional coverage of the celiac artery (CA) without
concomitant revascularization. This technique relies on
sufﬁcient collateral ﬂow between the CA and superior
mesenteric artery (SMA) to provide adequate perfusion
to the organs in the foregut. The purpose of this study is
to evaluate the published literature on the outcome of
intentional coverage of the CA during TEVAR.
METHODS
Search strategy and selection of articles. The
PubMed/Medline, Embase, and Scopus databases were






Duplication citation 90 163
Excluded as not relevant by title or
abstract
133 30
Citations identiﬁed through references of
reviewed manuscripts
4 34
Excluded (after review of manuscript)
Results not applicable 3 31
Aortic series without detailed






Duplicated cases 2 17
Included
Case reports with 59 cases 12
Aortic series with 34 cases 5
Table II. Availability of data in 17 studies on intentional
coverage of the CA during endovascular aortic repair
Patient data Availability
Patient age 17/17 (100%)
Gender 16/17 (94%)
Aortic pathology and acuity 17/17 (100%)
Preoperative imaging to assess CA-SMA
collateral ﬂow
17/17 (100%)
Endograft device 16/17 (94%)
Embolization of CA 17/17 (100%)
Treatment of SMA 17/17 (100%)
Postprocedure assessment of foregut perfusion 10/17 (59%)
Intraoperative complications 17/17 (100%)
Perioperative outcomes and mortality 17/17 (100%)
Postdischarge follow-up 14/16 (88%)
CA, Celiac artery; SMA, superior mesenteric artery.
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Cochrane database was browsed manually and did not
reveal any relevant articles. A total of 163 candidate
manuscripts were identiﬁed after duplicates were re-
moved. All titles and abstracts were reviewed by two inde-
pendent investigators (J.J., F.C.) to identify relevant
articles for further review. The full manuscripts were then
reviewed, and articles were included if they reported on
patients undergoing intentional coverage of the CA
during TEVAR. Furthermore, the reference lists of these
manuscripts were also reviewed to identify additional perti-
nent articles. Exclusion criteria included: (1) no clear
description of patient outcome; (2) no original data pre-
sented in the article (eg, review article); (3) concomitant
mesenteric revascularization. Articles written by identical
authors and/or institutions were analyzed, and only the
more recent publication was included to prevent duplica-
tion of data. Using the above search strategy (Table I),
a total of 17 articles were identiﬁed describing the outcome
of 93 patients; with 59 cases in 12 case reports and an
additional 34 cases from within ﬁve larger aortic case series.
Data extraction. The 17 articles consist of non-
randomized retrospective case reports or case series (largest
single report included 31 patients). There were no popula-
tion studies, comparative analyses, or randomized
controlled trials available. The data from this systematic
review were thus qualitatively analyzed but could not be
combined in a formal meta-analysis and presented as rec-
ommended by the Quality of Reporting of Meta-analyses
statement.17 Data were extracted from text, ﬁgures, or
tables and included the following: patient age, gender,
aortic pathology and acuity, preoperative imaging to assess
CA-SMA collateral ﬂow, endograft device, embolization of
CA, treatment of SMA, postprocedure assessment of
foregut perfusion, intraoperative complications, perioper-
ative outcomes and mortality, and follow-up complications.
The availability of patient data in the evaluated articles can
be found in Table II.RESULTS
Twelve studies identiﬁed were single cases or small series
on intentional coverage ofCAduringTEVAR(Table III). In
addition, ﬁve larger series on aortic intervention included
subgroups of patients undergoing intentional coverage of
CA (Table IV). The aortic pathology treated in the elective
(87%) setting included the following: 78 TAAs, one pene-
trating aortic ulcer, one type B aortic dissection, and one
distal type IB endoleak from a prior TEVAR. There were
12 patients (13%) treated for aortic rupture (10 TAAs and
twopenetrating aortic ulcers). These patients were described
as having “unstable rupture” (one), “stable rupture” (two),
“contained rupture” (three), and “massive hematoma”
(one), with the remaining ﬁve simply noted as “rupture.”
In 48 patients (52% of entire cohort), the preoperative
imaging study can be accurately determined and is as
follows: 15 (31%) computed tomography angiography
(CTA); 24 (50%) contrast angiography; and nine (19%)
contrast angiography with balloon occlusion of the CA.
The remaining 45 patients are derived from the two largest
series in this study, and the diagnostic study prior to inter-
vention is unclear. Mehta et al18 described their stepwise
diagnostic algorithm for their 31 patients: when a CTA fails
to demonstrate collaterals or aberrant replaced right hepatic
artery, a selective angiogram is performed. If this fails to
indicate collaterals, then temporary CA balloon occlusion
is obtained prior to SMA angiogram. The number of
patients requiring advanced diagnostic studies was not
detailed in their report. In their series of 16 patients, Leon
et al19 noted that two patients underwent balloon occlusion
(included above). However, the diagnostic test of choice for
the remaining 14 patients was not detailed.
The procedure was performed with a variety of endog-
rafts. As the studies included procedures performed in
countries across the globe, numerous different endografts
were utilized for these procedures. In 21 (23%) patients,
the CA was embolized (with either coils or occlusion
plug) prior to endograft deployment. Severe stenosis of
the CA was noted in two patients. There were no pre-
Table III. Case reports/series on intentional coverage of the CA during endovascular aortic repair
Author, year No. Age, years Gender Aortic pathology Follow-up, months
Saito 200620 1 79 M 1 TAA NA
Jorna 200634 1 79 F 1 rTAA 6
Aﬁﬁ 200938 1 76 F 1 rPAU NA
Belenky 200925 7 Mean, 74
Range, 54-84
5M, 2F 7 TAA 3-36
Faccenna 200922 1 71 M 1 TAA Died at 16 days
Hyklik-Durr 200923 5 Mean, 73
Range, 62-88
2M, 3F 2 rTAA, 1 PAU
1 TAA 1 type IB
Died at 1 day, 6 wk
15, 16, 31
Ishibashi 200939 2 Mean, 70
Range, 61-79
2M 2 TAA 4, 6
Mehta 201018 31 Mean, 74
Range, 55-87
11M, 20F 31 TAA Mean, 15
Shimazaki 201040 1 66 1F 1 TAA 3
Arismendi 201141 4 Range, 63-77 2M, 2F 4 TAA Mean, 10




Died at 2 days
7, 12, 14
Rabellino 201142 1 70 NA 1 TAA 6
CA, Celiac artery; F, female;M,male;NA, not available; PAU, penetrating aortic ulcer; rTAA, ruptured thoracic aortic aneurysm; rPAU, ruptured penetrating
aortic ulcer; TAA, thoracic aortic aneurysm; TBAD, type B aortic dissection; type IB, distal type IB endoleak.
Table IV. Aortic case series with subgroup of patients undergoing intentional coverage of the CA during endovascular
aortic repair
Author, year No. (total) Age, yearsa Gendera Aortic pathology Follow-up, monthsa
Waldenberger 200721 5 (10) Mean, 67
Range, 49-79
8M, 2F 5 TAA Mean, 21.4
Leon 200919 16 (19) Mean, 74
Range, 56-86
11M, 8F 14 TAA
2 rTAA
Mean, 8.7
Brinster 201026 4 (6) Mean, 76
Range, 70-83
2M, 4F 4 TAA Mean, 30.5
Delle 201024 8 (9) Mean, 73
Range, 53-81
6M, 3F 2 rTAA, 1 rPAU
5 TAA
Range, 14-56
Tholpady 201043 1 (14) 74b Fb 1 TAAb 17b
CA, Celiac artery; F, female; M, male; rPAU, ruptured penetrating aortic ulcer; rTAA, ruptured thoracic aortic aneurysm; TAA, thoracic aortic aneurysm.
aInformation from the entire series of patients.
bExact patient data were able to be extracted from this series, which contained 14 total patients.
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(19%) patients during their operative procedure. Of these,
one was stented as a part of a branched endograft.20
Twelve patients had partial coverage of the SMA during
endograft deployment, and a balloon-expandable stent
was placed to protect visceral ﬂow.18 Four patients had
placement of the thoracic endograft to immediately above
the most cranial renal artery with simultaneous stenting of
SMA as a “periscope graft.”16 One patient underwent
delayed SMA stent placement on postoperative day 2.21
The patient had “subtotal (98%) stenosis of the CA” and
developed abdominal pain 2 days after the intervention.
A CT showed bowel loops that were slightly thick
walled. Subsequent angiography “showed that a stent strut
of the lower edge of the Gore aortic prosthesis was partially
covering the branching of the SMA, causing a functional
decrease in perfusion.” After SMA stent placement, the
patient was free of pain. Postprocedure assessment of fore-
gut perfusion was reported in 47 (51%) patients with liver
perfusion or retrograde ﬁlling of the CA on completion
angiogram. Intraoperative complications occurred in ﬁve(5.4%) patients with iliac access vessel injuries. Four were
treated with endovascular stent placement, and one
required emergent iliofemoral bypass.
The 30-day mortality rate was 9.7% (nine patients)
with three deaths directly attributed to foregut ischemia.
This included a 71-year-old male treated electively for a
7.3-cm TAA.22 A preoperative angiogram “revealed good
collateral pathway between SMA and CA via gastroduo-
denal artery.” He developed worsening pancreatitis and
massive spleen infarction and died from multiorgan failure
(MOF) on the 16th postoperative day. An 88-year-old died
of MOF (with signiﬁcantly increased liver enzymes) 1 day
after successful exclusion of a ruptured TAA.23 The authors
reported that the CA was patent preoperatively, but “no
collateral ﬂow estimation” was performed due to the emer-
gent nature of the procedure. The third patient developed
on postoperative day 1 “shock liver and required emergent
right renal-to-hepatic artery revascularization and died.
A preoperative CTA indicated gastroduodenal collateral
pathways between the CA and the SMA.”18 Two patients
died of complications related to an acute myocardial
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 1 Jim et al 273infarction. An 80-year-old male with a ruptured TAA and
intraoperative hemodynamic instability developed abdom-
inal compartment syndrome and died from MOF on post-
operative day 2.16 The cause of death for the remaining
three patients was not clearly detailed.19
Foregut-related complications (in addition to three
deaths above) occurred in ﬁve additional patients. One
developed acalculus cholecystitis and underwent a success-
ful open cholecystectomy.18 Four patients developed the
following: “ischemic gastropathy with perforated ulcer,
liver abscess, worsening of liver cirrhosis, gallbladder
ischemia, and necrosis.”19 The speciﬁc clinical outcome
of these four patients was not detailed in the manuscript.
Three patients had transient elevation of their liver function
tests, which all resolved without intervention.24 Paraplegia
developed in four patients, and one other patient devel-
oped a transient paraparesis, which resolved after place-
ment of a lumbar drain.
The duration of follow-up for this cohort varied widely
(Tables III and IV). Distal type Ib endoleaks were found in
six (6.5%) patients. Four18,25,26 required placement of an
additional stent graft distally, and two18 were successfully
treated with transfemoral coil embolization. Three patients
underwent successful coil embolization for type II endoleaks
via retrograde ﬂow from the CA.18 Three additional endo-
leaks (two type I and one type II) were reported but not
further characterized and their clinical course unknown.19
DISCUSSION
A sufﬁcient landing zone is required for optimal endog-
raft ﬁxation in TEVAR to ensure durable clinical success. In
cases where the proximal landing zone is inadequate,
coverage of the left subclavian artery (with or without
revascularization) or extra-anatomic revascularization are
accepted techniques to expand the use of TEVAR to treat
patients with TAAs.3,4 However, optimal treatment in
patients with insufﬁcient distal landing zones remains
unclear. Intentional ligation of the CA in the treatment of
TAAs was ﬁrst described by Lawrence-Brown et al in
2000.27 In a hybrid open-endoluminal technique, a Dacron
band was sutured to the aorta and endograft to increase
distal ﬁxation, and the CA was ligated to prevent retrograde
ﬁlling of the aneurysm sac. In 2006, Saito et al described the
ﬁrst case of intentional coverage of the CA in a total endo-
vascular repair with use of a branched endograft.20
Intentional coverage of the CA may be tolerated due to
the presence of a collateral network of vessels between the
CA and the SMA. The major pathways include the pancrea-
ticoduodenal arcade (which connects the gastroduodenal
artery to the SMA) and the dorsal pancreatic arteries.28
Normal anatomic variants in hepatic arterial circulation
(such as a “replaced right hepatic artery”) may also provide
additional collateral ﬂow. Intentional ligation of the CA in
select clinical situations (such as trauma or malignancy)
have been reported without adverse outcomes.29,30 The
potential increase in landing zone length gained by CA
coverage varies. In cadaveric anatomic studies, the mean
distance between the oriﬁces of the CA and SMA has beenreported to be 9.2 to 15.2 mm.31,32 Preoperative demon-
stration of adequate collateral circulation between the celiac
and SMA is mandatory prior to considering intentional
coverage of the CA. However, there remains no consensus
in the literature regarding the optimal imaging modality.
Hyhlik-Durr and colleagues advocate that noninvasive
CTA may be sufﬁcient and obviate the need for selective
angiography.23 However, Gawenda et al argue that CTA
alone cannot replace angiography in the evaluation of collat-
eralization.33 To further demonstrate the presence of collat-
eral circulation, SMA angiography during temporary CA
balloon occlusion has also been described and considered
mandatory by some.34,35 Our review provided no deﬁnitive
evidence supporting a particular approach. However,
comparative studies have shown that CTA has an overall
accuracy of >90% in depicting mesenteric anatomy
compared with invasive angiography.36 As such, we feel
that the step-wise algorithm described by Mehta et al
(CTA and only if necessary, selective angiogram or balloon
occlusion) should be utilized to demonstrate adequate
collateral circulation while avoiding an unnecessary invasive
procedure.18 It is important to note that a history of foregut
(gastric or pancreatic) surgerymay be a relative contraindica-
tion to intentional coverage of theCA, as the collateral circu-
lation is often disrupted during these procedure.
This review showed that intentional coverage of the
CA can be performed with a wide variety of endografts,
as the use of various devices in the United States, Europe,
and Asia was reported in the literature. Embolization of the
CA prior to aortic endograft deployment is advocated by
some to prevent the potential development of a type II
endoleak into the aneurysm sac. However, only 21 (23%)
reported cases underwent this additional procedure. In
the remaining 72 patients, three (4%) developed a delayed
type II endoleak on CTA evaluation during postoperative
follow-up. These were all successfully treated by coil embo-
lization. As such, the authors feel that embolization of the
CA should not be considered as a mandatory adjunctive
procedure prior to TEVAR.
If the CA is covered, the abdominal organs rely
predominantly on the SMA to maintain adequate perfu-
sion. If there is underlying SMA occlusive disease, the
patient is at risk for developing mesenteric/visceral
ischemia after the procedure even in the presence of an
adequate collateral network. As such, the presence of
underlying SMA occlusive disease must be properly evalu-
ated prior to endograft deployment. Furthermore, SMA
patency must be ensured at the end of the procedure.
This review showed that 18 (19%) patients required place-
ment of an SMA stent during their procedure. Four were
performed as a periscope graft with endograft coverage
just proximal to the renal arteries, and another was done
with the placement of a branched endograft. There were
12 patients that had partial coverage of the SMA by the
endograft, and each was preemptively treated with the
placement of a balloon-expandable stent to maintain
patency of the SMA. There was one patient that developed
delayed abdominal pain 2 days after TEVAR. The
Table V. Complications for patients undergoing




Iliac access injury 5
Perioperative (<30 days)
Death (all-cause) 9
Death (from foregut ischemia) 3
Foregut-related complicationsa 5
Transient elevation of LFTs with resolution 3
Paraplegia 4
Transient paraparesis 1
CA, Celiac artery; LFTs, liver function tests.
aIncluding “ischemic gastropathy with perforated ulcer, liver abscess,
worsening of liver cirrhosis, gallbladder ischemia, and necrosis.”40
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angiography revealed partial coverage of the SMA oriﬁce.
As the development of mesenteric ischemia can lead to
serious and often fatal consequences, SMA patency must
be protected if intentional coverage of the CA is per-
formed. The simple technique of placing a long sheath or
guiding catheter into the SMA during endograft deploy-
ment can protect the SMA oriﬁce and facilitate stent place-
ment should this be required.
Intentional coverage of the CA during TEVAR can be
performed with good technical success (Table V). There
were ﬁve cases of intraoperative iliac artery injury requiring
treatment. This is within the reported range of access
complication in other large TEVAR series and likely not
related to coverage of the CA. However, the development
of foregut ischemia is of particular concern with this tech-
nique and occurred in 12% (three deaths, ﬁve with clinical
symptoms, three with transient elevation of liver enzymes)
of patients. As such, during the postoperative period, there
must be a heightened vigilance for mesenteric ischemia and
intervention with revascularization should not be delayed if
signs or symptoms develop. Paraplegia developed in four
(4.3%) cases with one additional case of transient parapare-
sis that resolved with spinal drain placement. While this
again is similar to the reported rate of spinal cord ischemia
for TEVAR in the literature, placement of a cerebral spinal
drainage catheter should be considered in these patients if
there is extensive coverage of the thoracic aorta.37
With the extension of a short distal landing zone, the
development of distal type IB endoleaks is of particular
concern even in the setting of CA coverage. There were
six (6.5%) cases of delayed distal type IB endoleaks found
on follow-up imaging. Two patients were successfully
treated by transfemoral coil embolization. The remaining
four patients were treated with placement of a distal endog-
raft. Two patients had migration from the distal attachment
site, and the other two patients had residual distal landing
zone proximal to the SMA. These cases perhaps highlight
the importance of placing the distal extent of the endograft
just proximal to the oriﬁce of the SMA in order to prevent
delayed distal endoleak.Intentional coverage of the CA broadens the application
of TEVAR to patients that otherwise have an inadequate
distal landing zone for endovascular treatment. This tech-
nique is predicated upon sufﬁcient collateral ﬂow between
the CA and SMA. However, this literature review showed
that development of foregut ischemia cannot be safely pre-
dicted even if adequate collateralization was demonstrated
preoperatively. It should be noted that only short- and
midterm follow-up were reported in the literature, and the
current data may not translate to long-term durable results.
Furthermore, the available literature is limited to case reports
and small series with no observation studies or comparative
reports. As such, there is likely a publication bias toward
successful outcomes, and this may lead to minimization of
the potential adverse outcomes of this technique.
CONCLUSIONS
The available evidence shows that intentional coverage
of the CA can be performed with technical success in
patients otherwise not suitable for standard TEVAR.
Nonetheless, there remains a signiﬁcant risk of postopera-
tive death and morbidity. Careful patient selection, preop-
erative determination of adequate CA-SMA collaterals, and
demonstration of postprocedure SMA patency are all
mandatory components of this procedure. However, the
development of foregut ischemia cannot be reliably pre-
dicted, and patients should be monitored closely for this
unique postoperative complication.
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